Position in PROF
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$67,379
+$23,639 QoQ
Shares Held
10,398
+73.3% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PROF Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $192,891,387 across 50 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
509,302 | $46,214,063 | |
| 2 | STE |
STERIS plc
|
209,519 | $44,118,415 | |
| 3 | SYK |
Stryker Corp
|
138,667 | $43,657,918 | |
| 4 | MDT |
Medtronic plc
|
258,603 | $20,230,512 | |
| 5 | EW |
Edwards Lifesciences Corp
|
60,926 | $5,511,365 | |
| 6 | BSX |
Boston Scientific Corp
|
123,736 | $5,281,052 | |
| 7 | DXCM |
Dexcom Inc
|
47,517 | $3,200,269 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
47,861 | $3,063,582 |
All Filings in PROF
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $67,379 | 10,398 | Shares | Sole | 2026-05-15 | |
| 2022-06-30 | $43,740 | 6,000 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $54,000 | 6,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $67,380 | 6,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $87,840 | 6,000 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $99,796 | 6,100 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $122,854 | 6,100 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $125,416 | 6,100 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||